RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Still no news? January 2018, it was at 25c per share.
Reality is tough to swallow with this company. It is a culmination of years of missed opportunity, empty promises, and regulatory issues that have led to a 90% drop in share price.
Bioganix was a successful, profitable and growing $4 million/year company prior to its acquisition. Under RLV's leadership, it is now generating revenues under $1 million, with net losses of ~$2 million.
Biocannabix is a pipe dream that, for three years, promised a license, a facility in Bille-St-Laurent, a Columbia Grow Operation, an acquisition of Weedsense and Cannakids....absolutely nothing has come of any of it.
Hand Sanitizer announced preorders of $250k and national distribution with The Paper Store. In the following year, no revenues or customers were shared in public financial filings.
PPE was hailed as the savior business during the global pandemic. One single order was announced in September 2020, and was announced to be shipping in October. No revenues have ever been booked, and promises to ship in April never materialized, then May came and went, and now a halt.
If I misread your note and you are in fact objective rather than trying to defend, state that.
Timoilers wrote: Show us where it was 9 times higher. Little boy.